Sharp, BSM Enter Agreement

Sharp confirmed a preferred partner agreement with innovative sterile manufacturer Berkshire Sterile Manufacturing (BSM).

As part of the agreement, Sharp will offer sterile fill/finish to augment its existing clinical manufacturing service to the pharmaceutical, biotech and clinical research sectors. 
Massachusetts-based BSM is a fill/finish contract manufacturer incorporating 100% isolator-based sterile filling to its lines for syringes, vials and cartridges for the biotech and pharmaceutical industries.  The isolator-based filling technology removes the risk of human contamination from the formulation and filling process.

Shawn Kinney, chief executive officer of BSM said, "We are excited to be working with Sharp, a high-quality contract services organisation that can offer our clients downstream packaging, labelling, storage and distribution services in a fully seamless manner."

Through the partnership, BSM will be able to offer its clients a comprehensive portfolio of complementary clinical trial supply and management services including analytical testing, stability, clinical and commercial packaging, serialisation, IRT services, QP services, storage and distribution.

Frank Lis, president at Sharp Clinical, said, "This partnership with BSM is a natural extension to the clinical services we offer our clients and one that will see both parties benefit greatly from each other's experience and expertise. BSM will be able to offer broader clinical trial services to its clients and a more harmonised customer experience, while Sharp will deepen its clinical manufacturing capabilities."

The Sharp BSM partnership agreement comes into effect immediately.

-------------------------------------------------

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.